Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.

Recent evidence of a protective immune response to the flavivirus non-structural protein, NS1, has suggested its incorporation into possible recombinant vaccines. The region of the 17D yellow fever virus (YFV) genome encoding the C terminus of envelope glycoprotein and extending to the N terminus of non-structural protein NS3 (NS1-NS2a-NS2b; nucleotides 2030 to 4940) was expressed in vaccinia virus and physical and immunogenic properties of the NS1 moiety were studied. Recombinant NS1 protein, and native YFV NS1, was detected at the surface of infected cells by immunofluorescence and by immune cytolysis after treatment with anti-NS1 antibody and complement. NS1 was also detected in the extracellular medium as a secreted form. Recombinant NS1 was immunoprecipitated as a single protein of approximately the same size as native 17D YFV NS1. Unboiled, both recombinant and native NS1 formed polymers of high Mr. Immunization of mice with this recombinant vaccinia virus stimulated production of non-neutralizing, complement-fixing cytolytic antibody and conferred partial protection against lethal intracerebral inoculation of mice with live 17D YFV.

[1]  M. Cochran,et al.  Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine. , 1990, The American journal of tropical medicine and hygiene.

[2]  J. Schlesinger,et al.  Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. , 1990, The Journal of general virology.

[3]  F. Ennis,et al.  Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes , 1989, Journal of virology.

[4]  R. Chanock,et al.  Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis , 1989, Journal of virology.

[5]  R. Chanock,et al.  Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a , 1989, Journal of virology.

[6]  R. Chanock,et al.  Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis , 1988, Journal of virology.

[7]  E. Gould,et al.  Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment. , 1988, The Journal of general virology.

[8]  A. Barrett,et al.  Prospects for a virus non-structural protein as a subunit vaccine. , 1988, Vaccine.

[9]  J. Schlesinger,et al.  Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. , 1987, The Journal of general virology.

[10]  C. B. Cropp,et al.  Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1 , 1986, Journal of virology.

[11]  A. Barrett,et al.  Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. , 1986, The Journal of general virology.

[12]  B. Moss,et al.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques , 1985, Molecular and cellular biology.

[13]  J. Schlesinger,et al.  Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. , 1985, Journal of immunology.

[14]  J. H. Strauss,et al.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. , 1985, Science.

[15]  T. Monath,et al.  Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. , 1983, Virology.

[16]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[17]  Hugh H. Smith,et al.  THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS , 1937, The Journal of experimental medicine.

[18]  V. Stollar,et al.  Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. , 1988, Virology.

[19]  J. H. Strauss,et al.  Structure of the Flavivirus Genome , 1986 .